journal article Feb 23, 2006

NMR and Crystallographic Characterization of Adventitious Borate Binding by Trypsin

View at Publisher Save 10.1021/bc0502210
Topics

No keywords indexed for this article. Browse by subject →

References
41
[1]
Drews J. (1998)
[2]
Druggability Indices for Protein Targets Derived from NMR-Based Screening Data

Philip J. Hajduk, Jeffrey R. Huth, Stephen W. Fesik

Journal of Medicinal Chemistry 2005 10.1021/jm049131r
[3]
Pizer R. (1984)
[4]
Coddington J. M. J. Coord. Chem. (1989) 10.1080/00958978909408845
[5]
Vandenberg R. Carbohydr. Res. (1994)
[6]
van Haveren J. (1989)
[7]
London R. E. J. Am. Chem. Soc. (1994)
[8]
Taler G. Inorg. Chim. Acta (1998) 10.1016/s0020-1693(97)06059-3
[9]
Taler G. J. Magn. Reson. (1999) 10.1006/jmre.1999.1853
[10]
Reuter W. (1999)
[11]
Vos S. J. Mol. Biol. (1998)
[12]
Tulinsky A. J. Biol. Chem. (1987) 10.1016/s0021-9258(18)47630-2
[13]
Adebodun F. J. Am. Chem. Soc. (1988) 10.1021/ja00209a060
[14]
Baldwin J. E. Bioorg. Med. Chem. Lett. (1991)
[15]
Tsilikounas, E., Kettner, C. A., and Bachovchin, W. W. (1993) Boron-11 NMR spectroscopy of peptide boronic acid inhibitor complexes of α-lytic protease − direct evidence for tetrahedral boron in both boron−histidine and boron−serine adduct complexes.Biochemistry 32, 12651−12655. 10.1021/bi00210a013
[16]
Tsilikounas E. (1992)
[17]
Bone R. (1991)
[18]
Bone R. (1989)
[19]
Stoll, V. S., Eger, B. T., Hynes, R. C., Martichonok, V., Jones, J. B., and Pai, E. F. (1998) Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors:  crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes.Biochemistry 37, 451−462. 10.1021/bi971166o
[20]
Holyoak T. (2003)
[21]
Wang X. (2003)
[22]
Chen Y. J. Am. Chem. Soc. (2005)
[23]
Nicola G. (2005)
[24]
London R. E. (2002)
[25]
Transue T. R. (2004)
[26]
Otwinowski Z. (1997)
[27]
Brunger A. T. Acta Crystallogr. (1998)
[28]
A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules

Wendy D. Cornell, Piotr Cieplak, Christopher I. Bayly et al.

Journal of the American Chemical Society 1995 10.1021/ja00124a002
[29]
Werbelow L. G. J. Phys. Chem. (1981) 10.1021/j150625a035
[30]
Babine R. E. Lett. Drug Des. Discovery (2004) 10.2174/1570180043485617
[31]
Sheidig, A. J., Hynes, T. R., Pelletier, L. A., Wells, J. A., and Kossiakoff, A. A. (1997) Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid β-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI):  Engineering of inhibitors with altered specifities.Protein Sci. 6, 1806−1824. 10.1002/pro.5560060902
[32]
Werbelow L. G. J. Chem. Phys. (1979) 10.1063/1.437471
[33]
Werbelow L. G. J. Magn. Reson. (1981)
[34]
Werbelow, L. G. (1995) inEncyclopedia of Nuclear Magnetic Resonance(Grant, D. M., Ed.) Vol. 6, pp 4092−4102, John Wiley & Sons, New York.
[35]
Aramini J. (1998)
[36]
Babcock L. (1980)
[37]
London R. E. J. Am. Chem. Soc. (1994)
[38]
Viscosity (1995)
[39]
Antonov V. K. (1968)
[40]
Chapelle, S., and Verchere, J.F. (1988) A11B and13C NMR determination of the structures of borate complexes of pentoses and related sugars.Tetrahedron 44, 4469−4482. 10.1016/s0040-4020(01)86149-4
[41]
Menard R. (1992)
Cited By
26
Boron Containing Compounds as Protease Inhibitors

Reem Smoum, Abraham Rubinstein · 2012

Chemical Reviews
Metrics
26
Citations
41
References
Details
Published
Feb 23, 2006
Vol/Issue
17(2)
Pages
300-308
Cite This Article
Thomas R. Transue, Scott A. Gabel, Robert E. London (2006). NMR and Crystallographic Characterization of Adventitious Borate Binding by Trypsin. Bioconjugate Chemistry, 17(2), 300-308. https://doi.org/10.1021/bc0502210